Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies

OBJECTIVE: Chemotherapy-induced nausea and vomiting (CINV) are common with doxorubicin-cyclophosphamide (AC) chemotherapy. Recommended antiemetic regimens incorporate neurokinin-1 receptor antagonist (NK1RA), 5-hydroxytryptamine type-3 receptor antagonist (5HT3RA), corticosteroid, and dopamine antag...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, Winnie, Li, Leung, Lau, Thomas KH, Lai, Kwai T, Chan, Vicky TC, Wong, Kwan H, Yip, Christopher CH, Pang, Elizabeth, Cheung, Maggie, Chan, Vivian, Kwok, Carol CH, Suen, Joyce JS, Mo, Frankie KF
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330523/
https://www.ncbi.nlm.nih.gov/pubmed/33710814
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330523/
https://www.ncbi.nlm.nih.gov/pubmed/33710814
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0241

Ejemplares similares